EVALUATION OF COMMON INTERACTIONS INCLUDING ANTI-INFECTIVE DRUGS IN PATIENTS UNDERWENT AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION

Objective: Hematopoietic stem cell transplantation is a challenging process involving polypharmacy. Drug-drug interactions are common due to the large number of drugs used in patients, and antiinfectives are frequently involved in interactions due to their widespread use. Methodology: In our study,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ayse Gunay, Eren Demirpolat, Ali Unal
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/f28a9a6c7da14af1830c2c7700244aea
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f28a9a6c7da14af1830c2c7700244aea
record_format dspace
spelling oai:doaj.org-article:f28a9a6c7da14af1830c2c7700244aea2021-11-10T04:37:17ZEVALUATION OF COMMON INTERACTIONS INCLUDING ANTI-INFECTIVE DRUGS IN PATIENTS UNDERWENT AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION2531-137910.1016/j.htct.2021.10.1054https://doaj.org/article/f28a9a6c7da14af1830c2c7700244aea2021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2531137921012013https://doaj.org/toc/2531-1379Objective: Hematopoietic stem cell transplantation is a challenging process involving polypharmacy. Drug-drug interactions are common due to the large number of drugs used in patients, and antiinfectives are frequently involved in interactions due to their widespread use. Methodology: In our study, the drugs used by a total of 100 patients with 50 autologous and 50 allogeneic bone marrow transplants for 10 days before transplantation, on the day of transplantation and for 10 days after transplantation were examined retrospectively in terms of interaction. Two paid softwares and two free softwares were used to examine interactions. The obtained data were analyzed with Microsoft Excel program. Results: 1017 different interactions were detected in patients with allogeneic bone marrow transplantation and 725 different interactions in patients with autologous bone marrow transplantation. It was observed that 342 interactions were common in the two transplant types. Interactions involving anti-infectives have been studied and the data showed antifungals, antibacterials and antivirals cause significant interaction load. Some interactions were found to be dependent on the transplant process. Conclusion: Allogeneic bone marrow transplantation and autologous bone marrow transplantation are challenging processes in which intensive drug therapy is applied. Knowing the interactions that are common to both types of transplantation and the interactions involving anti-infectives specific to a certain period of the transplantation process allows the process to be managed effectively. It is important to manage interactions in physician-clinical pharmacist collaborationAyse GunayEren DemirpolatAli UnalElsevierarticleDiseases of the blood and blood-forming organsRC633-647.5ENHematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S49- (2021)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the blood and blood-forming organs
RC633-647.5
spellingShingle Diseases of the blood and blood-forming organs
RC633-647.5
Ayse Gunay
Eren Demirpolat
Ali Unal
EVALUATION OF COMMON INTERACTIONS INCLUDING ANTI-INFECTIVE DRUGS IN PATIENTS UNDERWENT AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION
description Objective: Hematopoietic stem cell transplantation is a challenging process involving polypharmacy. Drug-drug interactions are common due to the large number of drugs used in patients, and antiinfectives are frequently involved in interactions due to their widespread use. Methodology: In our study, the drugs used by a total of 100 patients with 50 autologous and 50 allogeneic bone marrow transplants for 10 days before transplantation, on the day of transplantation and for 10 days after transplantation were examined retrospectively in terms of interaction. Two paid softwares and two free softwares were used to examine interactions. The obtained data were analyzed with Microsoft Excel program. Results: 1017 different interactions were detected in patients with allogeneic bone marrow transplantation and 725 different interactions in patients with autologous bone marrow transplantation. It was observed that 342 interactions were common in the two transplant types. Interactions involving anti-infectives have been studied and the data showed antifungals, antibacterials and antivirals cause significant interaction load. Some interactions were found to be dependent on the transplant process. Conclusion: Allogeneic bone marrow transplantation and autologous bone marrow transplantation are challenging processes in which intensive drug therapy is applied. Knowing the interactions that are common to both types of transplantation and the interactions involving anti-infectives specific to a certain period of the transplantation process allows the process to be managed effectively. It is important to manage interactions in physician-clinical pharmacist collaboration
format article
author Ayse Gunay
Eren Demirpolat
Ali Unal
author_facet Ayse Gunay
Eren Demirpolat
Ali Unal
author_sort Ayse Gunay
title EVALUATION OF COMMON INTERACTIONS INCLUDING ANTI-INFECTIVE DRUGS IN PATIENTS UNDERWENT AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION
title_short EVALUATION OF COMMON INTERACTIONS INCLUDING ANTI-INFECTIVE DRUGS IN PATIENTS UNDERWENT AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION
title_full EVALUATION OF COMMON INTERACTIONS INCLUDING ANTI-INFECTIVE DRUGS IN PATIENTS UNDERWENT AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION
title_fullStr EVALUATION OF COMMON INTERACTIONS INCLUDING ANTI-INFECTIVE DRUGS IN PATIENTS UNDERWENT AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION
title_full_unstemmed EVALUATION OF COMMON INTERACTIONS INCLUDING ANTI-INFECTIVE DRUGS IN PATIENTS UNDERWENT AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION
title_sort evaluation of common interactions including anti-infective drugs in patients underwent autologous and allogeneic stem cell transplantation
publisher Elsevier
publishDate 2021
url https://doaj.org/article/f28a9a6c7da14af1830c2c7700244aea
work_keys_str_mv AT aysegunay evaluationofcommoninteractionsincludingantiinfectivedrugsinpatientsunderwentautologousandallogeneicstemcelltransplantation
AT erendemirpolat evaluationofcommoninteractionsincludingantiinfectivedrugsinpatientsunderwentautologousandallogeneicstemcelltransplantation
AT aliunal evaluationofcommoninteractionsincludingantiinfectivedrugsinpatientsunderwentautologousandallogeneicstemcelltransplantation
_version_ 1718440612733124608